IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 228 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $792,000 | -65.9% | 25,000 | -50.0% | 0.01% | -60.0% |
| Q4 2020 | $2,320,000 | -68.0% | 50,000 | -77.3% | 0.02% | -81.9% |
| Q3 2020 | $7,242,000 | +427.5% | 219,982 | +340.0% | 0.14% | +273.0% |
| Q2 2020 | $1,373,000 | +83.6% | 50,000 | +100.0% | 0.04% | +19.4% |
| Q1 2020 | $748,000 | -80.1% | 25,000 | -81.6% | 0.03% | -74.8% |
| Q4 2019 | $3,766,000 | +67.4% | 136,040 | +10.1% | 0.12% | +36.7% |
| Q3 2019 | $2,250,000 | +22.3% | 123,599 | +64.8% | 0.09% | +109.3% |
| Q2 2019 | $1,839,000 | +28.9% | 75,000 | -50.0% | 0.04% | -2.3% |
| Q1 2019 | $1,427,000 | +7.5% | 150,000 | 0.0% | 0.04% | -17.0% |
| Q4 2018 | $1,328,000 | -5.5% | 150,000 | +20.0% | 0.05% | +76.7% |
| Q3 2018 | $1,406,000 | +119.7% | 125,000 | +150.0% | 0.03% | +87.5% |
| Q2 2018 | $640,000 | – | 50,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 2,222,701 | $25,005,000 | 8.92% |
| Broadfin Capital, LLC | 4,894,361 | $55,062,000 | 8.10% |
| GREAT POINT PARTNERS LLC | 3,496,340 | $39,334,000 | 6.13% |
| FRAZIER MANAGEMENT LLC | 2,188,331 | $24,619,000 | 4.51% |
| Prosight Management, LP | 715,317 | $8,047,000 | 4.49% |
| Avoro Capital Advisors LLC | 8,662,720 | $97,456,000 | 4.48% |
| QVT Financial LP | 821,361 | $8,748,000 | 2.26% |
| Perceptive Advisors | 7,290,199 | $82,014,000 | 2.19% |
| Rhenman & Partners Asset Management AB | 1,290,495 | $14,518,000 | 1.46% |
| EMORY UNIVERSITY | 185,915 | $2,092,000 | 1.37% |